Apremilast for Erythema Multiforme

Clinical trial NCT05875714 · COMPLETED

Trial details

NCT number: NCT05875714
Sponsor: Robert Micheletti
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Erythema Multiforme

Start date: 2022-01-13
Primary completion: 2024-12-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.